{"entity":{"type":"insider","cik":"0001478916","url":"/insider/0001478916","json_url":"/insider/0001478916.json","name":"Schmid John P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":33,"n_filings":27,"first":"2011-03-03","last":"2026-08-10","span_basis":"filed_date"},"name_variants":[{"name":"Schmid John P.","source":"filing","n_filings":27,"first_seen":"2011-03-03","last_seen":"2026-08-10"}],"transactions":[{"id":9289669,"accession":"0001478916-26-000015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001478916-26-000015","line_url":"/filing/0001478916-26-000015#line-1","is_derivative":false,"issuer_cik":"0001478916","issuer_name":"BlossomHill Therapeutics, Inc.","issuer_ticker":"BLSM","issuer_name_source":null,"issuer_url":"/issuer/0001478916","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":96000.0,"total_display":"96,000.00","total_whole":"96,000","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-10","filed_date":"2026-08-10","scope":"insider"},{"id":5993903,"accession":"0001478916-26-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001478916-26-000004","line_url":"/filing/0001478916-26-000004","is_derivative":false,"issuer_cik":"0001370053","issuer_name":"ANAPTYSBIO, INC","issuer_ticker":"ANAB","issuer_name_source":null,"issuer_url":"/issuer/0001370053","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20645.0,"shares_display":"20,645","price_per_share":56.11292886413175,"price_display":"56.11","price_state":"stated","total_value":1158451.4164,"total_display":"1,158,451.42","total_whole":"1,158,451","shares_owned_after":39671.0,"shares_owned_after_display":"39,671","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-30","filed_date":"2026-04-01","scope":"insider","n_lines":3},{"id":2296090,"accession":"0001867096-24-000176","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001867096-24-000176","line_url":"/filing/0001867096-24-000176#line-1","is_derivative":false,"issuer_cik":"0001478916","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001478916","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4515.0,"shares_display":"4,515","price_per_share":2.2474,"price_display":"2.25","price_state":"stated","total_value":10147.011,"total_display":"10,147.01","total_whole":"10,147","shares_owned_after":25200.0,"shares_owned_after_display":"25,200","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-12","filed_date":"2024-08-13","scope":"insider"},{"id":2072595,"accession":"0001867096-24-000173","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001867096-24-000173","line_url":"/filing/0001867096-24-000173#line-1","is_derivative":false,"issuer_cik":"0001478916","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001478916","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4285.0,"shares_display":"4,285","price_per_share":2.365,"price_display":"2.36","price_state":"stated","total_value":10134.025,"total_display":"10,134.02","total_whole":"10,134","shares_owned_after":20685.0,"shares_owned_after_display":"20,685","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-09","filed_date":"2024-08-12","scope":"insider"},{"id":2446005,"accession":"0001867096-24-000067","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001867096-24-000067","line_url":"/filing/0001867096-24-000067#line-1","is_derivative":false,"issuer_cik":"0001478916","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001478916","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5400.0,"shares_display":"5,400","price_per_share":1.91,"price_display":"1.91","price_state":"stated","total_value":10314.0,"total_display":"10,314.00","total_whole":"10,314","shares_owned_after":16400.0,"shares_owned_after_display":"16,400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-10","filed_date":"2024-05-10","scope":"insider"},{"id":2805647,"accession":"0001415889-24-009063","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-009063","line_url":"/filing/0001415889-24-009063#line-2","is_derivative":false,"issuer_cik":"0001478916","issuer_name":"Design Therapeutics, Inc.","issuer_ticker":"DSGN","issuer_name_source":null,"issuer_url":"/issuer/0001478916","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17809.0,"shares_display":"17,809","price_per_share":3.74,"price_display":"3.74","price_state":"stated","total_value":66605.66,"total_display":"66,605.66","total_whole":"66,606","shares_owned_after":26965.0,"shares_owned_after_display":"26,965","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-25","filed_date":"2024-03-25","scope":"insider"},{"id":2805640,"accession":"0001415889-24-009063","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-009063","line_url":"/filing/0001415889-24-009063#line-1","is_derivative":false,"issuer_cik":"0001478916","issuer_name":"Design Therapeutics, Inc.","issuer_ticker":"DSGN","issuer_name_source":null,"issuer_url":"/issuer/0001478916","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9156.0,"shares_display":"9,156","price_per_share":3.6187,"price_display":"3.62","price_state":"stated","total_value":33132.8172,"total_display":"33,132.82","total_whole":"33,133","shares_owned_after":9156.0,"shares_owned_after_display":"9,156","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-22","filed_date":"2024-03-25","scope":"insider"},{"id":2811209,"accession":"0001867096-24-000034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001867096-24-000034","line_url":"/filing/0001867096-24-000034#line-1","is_derivative":false,"issuer_cik":"0001478916","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001478916","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4500.0,"shares_display":"4,500","price_per_share":2.16,"price_display":"2.16","price_state":"stated","total_value":9720.0,"total_display":"9,720.00","total_whole":"9,720","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-14","filed_date":"2024-03-14","scope":"insider"},{"id":8692306,"accession":"0001867096-23-000147","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001867096-23-000147","line_url":"/filing/0001867096-23-000147#line-1","is_derivative":false,"issuer_cik":"0001478916","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001478916","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6500.0,"shares_display":"6,500","price_per_share":1.51,"price_display":"1.51","price_state":"stated","total_value":9815.0,"total_display":"9,815.00","total_whole":"9,815","shares_owned_after":6500.0,"shares_owned_after_display":"6,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-16","filed_date":"2023-11-17","scope":"insider"},{"id":2554944,"accession":"0001181431-12-037813","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-037813","line_url":"/filing/0001181431-12-037813#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":10800.0,"total_display":"10,800.00","total_whole":"10,800","shares_owned_after":107639.0,"shares_owned_after_display":"107,639","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-22","filed_date":"2012-06-25","scope":"insider"},{"id":3438325,"accession":"0001181431-12-013755","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-013755","line_url":"/filing/0001181431-12-013755#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":5.04,"price_display":"5.04","price_state":"stated","total_value":2520.0,"total_display":"2,520.00","total_whole":"2,520","shares_owned_after":104439.0,"shares_owned_after_display":"104,439","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-01","filed_date":"2012-03-02","scope":"insider"},{"id":3157485,"accession":"0001181431-12-006043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-006043","line_url":"/filing/0001181431-12-006043#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":5.63,"price_display":"5.63","price_state":"stated","total_value":2815.0,"total_display":"2,815.00","total_whole":"2,815","shares_owned_after":104939.0,"shares_owned_after_display":"104,939","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-02","filed_date":"2012-02-06","scope":"insider"},{"id":3293966,"accession":"0001181431-12-000623","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-000623","line_url":"/filing/0001181431-12-000623#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":7.28,"price_display":"7.28","price_state":"stated","total_value":5096.0,"total_display":"5,096.00","total_whole":"5,096","shares_owned_after":105439.0,"shares_owned_after_display":"105,439","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-01-03","filed_date":"2012-01-04","scope":"insider"},{"id":8976302,"accession":"0001181431-11-058407","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-058407","line_url":"/filing/0001181431-11-058407#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":7.5,"price_display":"7.50","price_state":"stated","total_value":5250.0,"total_display":"5,250.00","total_whole":"5,250","shares_owned_after":106139.0,"shares_owned_after_display":"106,139","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-01","filed_date":"2011-12-02","scope":"insider"},{"id":8955855,"accession":"0001181431-11-055261","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-055261","line_url":"/filing/0001181431-11-055261#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":700.0,"total_display":"700.00","total_whole":"700","shares_owned_after":106839.0,"shares_owned_after_display":"106,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-07","filed_date":"2011-11-08","scope":"insider"},{"id":9015401,"accession":"0001181431-11-054127","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-054127","line_url":"/filing/0001181431-11-054127#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":6.75,"price_display":"6.75","price_state":"stated","total_value":4050.0,"total_display":"4,050.00","total_whole":"4,050","shares_owned_after":106939.0,"shares_owned_after_display":"106,939","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-01","filed_date":"2011-11-01","scope":"insider"},{"id":8925713,"accession":"0001181431-11-053623","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-053623","line_url":"/filing/0001181431-11-053623#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":1400.0,"total_display":"1,400.00","total_whole":"1,400","shares_owned_after":107539.0,"shares_owned_after_display":"107,539","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-26","filed_date":"2011-10-27","scope":"insider"},{"id":9112238,"accession":"0001181431-11-051304","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-051304","line_url":"/filing/0001181431-11-051304#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":6.33,"price_display":"6.33","price_state":"stated","total_value":3798.0,"total_display":"3,798.00","total_whole":"3,798","shares_owned_after":107739.0,"shares_owned_after_display":"107,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-10-03","filed_date":"2011-10-04","scope":"insider"},{"id":9034927,"accession":"0001181431-11-048019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-048019","line_url":"/filing/0001181431-11-048019#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":6.6,"price_display":"6.60","price_state":"stated","total_value":3960.0,"total_display":"3,960.00","total_whole":"3,960","shares_owned_after":108339.0,"shares_owned_after_display":"108,339","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-01","filed_date":"2011-09-02","scope":"insider"},{"id":9161034,"accession":"0001181431-11-043320","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-043320","line_url":"/filing/0001181431-11-043320","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":8.852,"price_display":"8.85","price_state":"stated","total_value":10622.4,"total_display":"10,622.40","total_whole":"10,622","shares_owned_after":109339.0,"shares_owned_after_display":"109,339","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-01","filed_date":"2011-08-02","scope":"insider","n_lines":2},{"id":9161017,"accession":"0001181431-11-041911","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-041911","line_url":"/filing/0001181431-11-041911#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":800.0,"total_display":"800.00","total_whole":"800","shares_owned_after":110139.0,"shares_owned_after_display":"110,139","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-07-20","filed_date":"2011-07-21","scope":"insider"},{"id":9178755,"accession":"0001181431-11-039643","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-039643","line_url":"/filing/0001181431-11-039643#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":7.929,"price_display":"7.93","price_state":"stated","total_value":5550.3,"total_display":"5,550.30","total_whole":"5,550","shares_owned_after":110239.0,"shares_owned_after_display":"110,239","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-07-01","filed_date":"2011-07-05","scope":"insider"},{"id":9160860,"accession":"0001181431-11-034072","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-034072","line_url":"/filing/0001181431-11-034072","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":7.90375,"price_display":"7.90","price_state":"stated","total_value":6323.0,"total_display":"6,323.00","total_whole":"6,323","shares_owned_after":111039.0,"shares_owned_after_display":"111,039","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-01","filed_date":"2011-06-01","scope":"insider","n_lines":2},{"id":8842949,"accession":"0001181431-11-030666","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-030666","line_url":"/filing/0001181431-11-030666#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":3200.0,"total_display":"3,200.00","total_whole":"3,200","shares_owned_after":111739.0,"shares_owned_after_display":"111,739","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-16","filed_date":"2011-05-18","scope":"insider"},{"id":9070984,"accession":"0001181431-11-028066","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-028066","line_url":"/filing/0001181431-11-028066#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":1400.0,"total_display":"1,400.00","total_whole":"1,400","shares_owned_after":112139.0,"shares_owned_after_display":"112,139","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-05","filed_date":"2011-05-09","scope":"insider"},{"id":8903501,"accession":"0001181431-11-026666","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-026666","line_url":"/filing/0001181431-11-026666#line-2","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":1200.0,"total_display":"1,200.00","total_whole":"1,200","shares_owned_after":112339.0,"shares_owned_after_display":"112,339","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-03","filed_date":"2011-05-03","scope":"insider"},{"id":8903498,"accession":"0001181431-11-026666","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-026666","line_url":"/filing/0001181431-11-026666#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":5.62,"price_display":"5.62","price_state":"stated","total_value":2810.0,"total_display":"2,810.00","total_whole":"2,810","shares_owned_after":112539.0,"shares_owned_after_display":"112,539","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-02","filed_date":"2011-05-03","scope":"insider"},{"id":9131369,"accession":"0001181431-11-021675","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-021675","line_url":"/filing/0001181431-11-021675#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":5.66,"price_display":"5.66","price_state":"stated","total_value":2830.0,"total_display":"2,830.00","total_whole":"2,830","shares_owned_after":113039.0,"shares_owned_after_display":"113,039","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-01","filed_date":"2011-04-04","scope":"insider"},{"id":9092645,"accession":"0001181431-11-014955","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-014955","line_url":"/filing/0001181431-11-014955#line-1","is_derivative":false,"issuer_cik":"0001356857","issuer_name":"Trius Therapeutics Inc","issuer_ticker":"TSRX","issuer_name_source":null,"issuer_url":"/issuer/0001356857","owner_cik":"0001478916","owner_name":"Schmid John P.","owner_display_name":"Schmid John P.","owner_url":"/insider/0001478916","role":"Officer (CFO and Secretary)","role_mark":"O","role_mark_label":"Officer (CFO and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":7.04,"price_display":"7.04","price_state":"stated","total_value":9856.0,"total_display":"9,856.00","total_whole":"9,856","shares_owned_after":113539.0,"shares_owned_after_display":"113,539","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-01","filed_date":"2011-03-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":33,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":25,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":33},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001839970","name":"BlossomHill Therapeutics, Inc.","url":"/issuer/0001839970","role":"Director","n_filings":1,"first_seen":"2026-08-10","last_seen":"2026-08-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001370053","name":"ANAPTYSBIO, INC","url":"/issuer/0001370053","role":"Director","n_filings":1,"first_seen":"2026-04-01","last_seen":"2026-04-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001867096","name":"Xeris Biopharma Holdings, Inc.","url":"/issuer/0001867096","role":"Director","n_filings":5,"first_seen":"2023-11-17","last_seen":"2024-08-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001807120","name":"Design Therapeutics, Inc.","url":"/issuer/0001807120","role":"Director","n_filings":1,"first_seen":"2024-03-25","last_seen":"2024-03-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001356857","name":"Trius Therapeutics Inc","url":"/issuer/0001356857","role":"Officer (CFO and Secretary)","n_filings":19,"first_seen":"2011-03-03","last_seen":"2012-06-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001478916","retrieved_at":"2026-08-22T14:04:56+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}